COMPOUNDS FOR METABOLIC DISORDER TREATMENT Russian patent published in 2009 - IPC C07C321/26 A61K31/235 A61P3/04 A61P3/06 A61P3/08 A61P3/10 

FIELD: medicine.

SUBSTANCE: invention claims bioactive agent in the form of compound of formula (I) , where n is 1 or 2, m is 0, q is 0, t is 0, R⁹ is hydrogen, A is phenyl substituted by 1 or 2 groups selected out of alkyl with 1 or 2 carbon atoms, X is -CH₂CR¹²R¹³- group where each of R¹² and R¹³ is hydrogen, Q is OR¹, R¹ is hydrogen or alkyl with 1 to 7 carbon atoms, and agent application in medicine manufacturing for treatment of state selected out of group including resistance syndrome and diabetes.

EFFECT: method of treatment for mammal subject with state selected out of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver, cachexia, adiposity, atherosclerosis, and arteriosclerosis, involving daily oral administration of 1 to 400 mg of bioactive agent, and pharmaceutical composition based on the bioactive agent.

12 cl, 1 tbl, 2 ex